More on CRVO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.9 Score)

Upcoming Events

- Earnings (2/10/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CervoMed (NQ:CRVO)
Delayed: 4.11 +0.10 (2.49%)
Prev. Close $4.01  
Open$3.98 
52 Wk High$ 
52 Wk Low$ 
Day High$4.17 
Day Low$3.90 
P/E N/A  
EPS$ 
Volume45,523 

Friends, Peers and Foes (?): SCYX, AFDG, ATCH, BSAI, CCCM (more...)

Mar 5, 2026 07:30 AM CervoMed to Participate in Upcoming Investor Conferences
Mar 4, 2026 04:07 PM Form 8-K CervoMed Inc. For: Mar 04
Mar 4, 2026 07:30 AM CervoMed selects dosing for Phase 3 dementia with Lewy bodies trial
Mar 4, 2026 07:30 AM CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies
Feb 18, 2026 04:25 PM Form 8-K CervoMed Inc. For: Feb 18
Feb 18, 2026 06:02 AM CervoMed's neflamapimod selected for UK ALS trial platform
Feb 18, 2026 06:00 AM CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
Feb 17, 2026 08:00 AM CERo Therapeutics appoints Eric Francois to board of directors
Feb 17, 2026 08:00 AM CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors
Feb 13, 2026 05:03 PM Form 4 CervoMed Inc. For: Feb 11 Filed by: Winton Matthew
View All Articles

Entities mentioned with CRVO

View All Entities